
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Relmada Therapeutics (NASDAQ:RLMD) through any online brokerage.
Other companies in Relmada Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Relmada Therapeutics has a consensus price target of $10.00.
The stock price for Relmada Therapeutics (NASDAQ: RLMD) is $4.36 last updated August 31, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Relmada Therapeutics.
Relmada Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Relmada Therapeutics.
Relmada Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.